Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2569-2575

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brochériou, I.
Right arrow Articles by Ninio, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brochériou, I.
Right arrow Articles by Ninio, E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Other arteriosclerosis
Right arrow Carotid Stenosis

(Circulation. 2000;102:2569.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Expression of Platelet-Activating Factor Receptor in Human Carotid Atherosclerotic Plaques

Relevance to Progression of Atherosclerosis

Isabelle Brochériou, MD; Dominique Stengel, PhD; Lillemor Mattsson-Hultén, PhD; Jana Stankova, PhD; Marek Rola-Pleszczynski, PhD; Fabien Koskas, MD, PhD; Olov Wiklund, PhD; Yves Le Charpentier, MD, PhD; Ewa Ninio, PhD

From INSERM U321, Lipoproteins and Atherogenesis (I.B., D.S., E.N.); Laboratoire Central d’Anatomie Pathologique (I.B., Y.L.); and Département de Chirurgie Vasculaire (F.K.), Groupe Hospitalier Pitié-Salpêtrière, Paris, France; Wallenberg Laboratory, Sahlgrenska University Hospital, Göteborg, Sweden (L.M.-H., O.W.); and Service d’Immunologie, Département de Pédiatrie, Faculté de Médecine, Université de Sherbrooke, Quebec, Canada (J.S., M.R.-P.). Drs Brochériou, Stengel, and Ninio are now at INSERM U525, Génétique épidemiologique et moléculaire des pathologies cardiovasculaires, Institut Fédératif "Muscle Coeur et Vaisseaux," Groupe Hospitalier Pitié-Salpêtrière and UFR Médecine Sud (Université Pierre et Marie Curie), Paris, France.

Correspondence to Ewa Ninio, INSERM U525, Faculté de Médecine Pitié-Salpêtrière, 91, Bd. de l’Hôpital, 75634 Paris, Cedex 13, France. E-mail eninio{at}infobiogen.fr

Background—Human monocyte-derived macrophages synthesize numerous proinflammatory and prothrombotic substances, including lipid mediators, such as platelet-activating factor (PAF), which may play a major role in the onset and perpetuation of atherosclerotic lesions. In addition, both monocytes and macrophages express PAF receptors (PAF-R). The expression of PAF-R is transcriptionally downregulated by oxidized LDL in in vitro primary cultures of monocyte/macrophages. In this study, we evaluated the expression of PAF-R in human carotid plaque tissue, in foam cells isolated from human carotid plaques, and in primary cultures of umbilical smooth muscle cells (SMCs).

Methods and Results—We show that PAF-R was expressed at low levels in foam cells compared with monocyte/macrophages in plaques, as assessed by immunohistochemical staining and in situ hybridization. In addition, low levels of mRNA were also detected by RT-PCR in isolated human carotid foam cells. A prominent finding of our study was the demonstration that contractile SMCs were positive for PAF-R, and its mRNA was extracted from primary cultures of umbilical SMCs.

Conclusions—As macrophages loose their inflammatory phenotype on transformation into foam cells, they may equally loose their capacity of defense against aggression. We postulate that the diminished expression of PAF-R may be deleterious in the context of plaque formation and progression. The observation that arterial SMCs of contractile phenotype express PAF-R opens new avenues concerning the migration of these cells from media to intima and atherosclerotic plaque formation.


Key Words: atherosclerosis • macrophages • muscle, smooth • cells • lipoproteins




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. C. Tsoukatos, I. Brocheriou, V. Moussis, C. P. Panopoulou, E. D. Christofidou, S. Koussissis, S. Sismanidis, E. Ninio, and S. Siminelakis
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery
J. Lipid Res., October 1, 2008; 49(10): 2240 - 2249.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Slevin, A. B. Elasbali, M. Miguel Turu, J. Krupinski, L. Badimon, and J. Gaffney
Identification of Differential Protein Expression Associated with Development of Unstable Human Carotid Plaques
Am. J. Pathol., March 1, 2006; 168(3): 1004 - 1021.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
H. Hudry-Clergeon, D. Stengel, E. Ninio, and I. Vilgrain
Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase
FASEB J, April 1, 2005; 19(6): 512 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Dupre, Z. Chen, C. Le Gouill, C. Theriault, J.-L. Parent, M. Rola-Pleszczynski, and J. Stankova
Trafficking, Ubiquitination, and Down-regulation of the Human Platelet-activating Factor Receptor
J. Biol. Chem., November 28, 2003; 278(48): 48228 - 48235.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Russo, B. Bussolati, I. Deambrosis, F. Mariano, and G. Camussi
Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction
J. Immunol., November 15, 2003; 171(10): 5489 - 5497.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. D. Tselepis, S.-A. P. Karabina, D. Stengel, R. Piedagnel, M. J. Chapman, and E. Ninio
N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL
J. Lipid Res., October 1, 2001; 42(10): 1645 - 1654.
[Abstract] [Full Text] [PDF]